Histotype
Mammary/Breast
| Parameter | Information |
|---|---|
| Strain | Balb/c |
| Implant Type | Cells |
| Implant Location | Mammary Fat Pad |
| Time to Staging | 6 days |
| Time to Evaluation Size (days) | 21.5 days |
| Td | 5.2 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9160
Spotlight on EMT-6
Learn more about this cell line in our scientific spotlights:
Breast cancer is the most common cancer among women in the United States and is the fourth leading cause of cancer death. In 2017, an estimated 252,710 new cases were diagnosed (15% of all new cancers) and 40,610 patient deaths occurred. Early detection initiatives together with improved treatment options have resulted in increases in the 5-year overall survival rate from 75% in 1975 to over 90% today.[1] Despite the favorable survival statistics, metastatic disease continues to be a treatment challenge and often results in death. For this reason, the continual development of new treatments for breast cancer is necessary.